In breast cancer, the combined expression of CD44 and CD24, commonly reveals enrichment of the CD44−CD24+ and CD44+CD24Lo/− cell phenotypes in luminal and basal-like breast cancer cell lines, respectively [35,36]. Here, CD44 is linked to breast carcinoma.